Report Feature
• Novel Oral Anticoagulants
• Heparin & Low Molecular Weight Heparin
• Vitamin K Antagonist
• Others Anticoagulation Market by Route of Administration [Shipment Analysis by Value from 2018 to 2030]:
• Oral
• Injectable Anticoagulation Market by Application [Shipment Analysis by Value from 2018 to 2030]:
• Atrial Fibrillation/Myocardial Infarction
• Deep Vein Thrombosis
• Pulmonary Embolism
• Others Anticoagulation Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World List of Anticoagulation Companies Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies anticoagulation companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the anticoagulation companies profiled in this report include-
• Johnson & Johnson
• Bayer
• Boehringer Ingelheim
• Bristol-Myers Squibb
• Daiichi Sankyo Anticoagulation Market Insights Lucintel forecasts that novel oral anticoagulants is expected to witness the highest growth over the forecast period due to usage for the prevention and treatment of atrial fibrillation/myocardial infarction, deep vein thrombosis, and pulmonary embolism. Within this market, atrial fibrillation/myocardial infarction will remain the largest segment due to increased usage of anticoagulants in the treatment. North America is expected to witness highest growth over the forecast period due to high occurence of cardiovascular disorders. Features of the Global Anticoagulation Market Market Size Estimates: Anticoagulation market size estimation in terms of value ($B). Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions. Segmentation Analysis: Anticoagulation market size by drug class, route of administration, application, and region in terms of value ($B). Regional Analysis: Anticoagulation market breakdown by North America, Europe, Asia Pacific, and Rest of the World. Growth Opportunities: Analysis of growth opportunities in different drug class, route of administration, application, and regions for the anticoagulation market. Strategic Analysis: This includes M&A, new product development, and competitive landscape of the anticoagulation market. Analysis of competitive intensity of the industry based on Porter’s Five Forces model. FAQ Q1. What is the anticoagulation market size? Answer: The global anticoagulation market is expected to reach an estimated $43.065065225788 billion by 2030. Q2. What is the growth forecast for anticoagulation market? Answer: The global anticoagulation market is expected to grow with a CAGR of 7.0% from 2024 to 2030. Q3. What are the major drivers influencing the growth of the anticoagulation market? Answer: The major drivers for this market are growing prevalence of chronic diseases and growing adaption of novel oral anticoagulants. Q4. What are the major segments for anticoagulation market? Answer: The future of the anticoagulation market looks promising with opportunities in the atrial fibrillation/myocardial infarction, deep vein thrombosis, and pulmonary embolism markets. Q5. Who are the key anticoagulation market companies? Answer: Some of the key anticoagulation companies are as follows:
• Johnson & Johnson
• Bayer
• Boehringer Ingelheim
• Bristol-Myers Squibb
• Daiichi Sankyo Q6. Which anticoagulation market segment will be the largest in future? Answer: Lucintel forecasts that novel oral anticoagulants is expected to witness the highest growth over the forecast period due to usage for the prevention and treatment of atrial fibrillation/myocardial infarction, deep vein thrombosis, and pulmonary embolism. Q7. In anticoagulation market, which region is expected to be the largest in next 5 years? Answer: North America is expected to witness highest growth over the forecast period due to high occurence of cardiovascular disorders. Q.8 Do we receive customization in this report? Answer: Yes, Lucintel provides 10% customization without any additional cost. This report answers following 11 key questions: Q.1. What are some of the most promising, high-growth opportunities for the anticoagulation market by drug class (novel oral anticoagulants, heparin and low molecular weight heparin, vitamin K antagonist, and others), route of administration (oral and injectable), application (atrial fibrillation/myocardial infarction, deep vein thrombosis, pulmonary embolism, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)? Q.2. Which segments will grow at a faster pace and why? Q.3. Which region will grow at a faster pace and why? Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market? Q.5. What are the business risks and competitive threats in this market? Q.6. What are the emerging trends in this market and the reasons behind them? Q.7. What are some of the changing demands of customers in the market? Q.8. What are the new developments in the market? Which companies are leading these developments? Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth? Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution? Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry? For any questions related to Anticoagulation Market, Anticoagulation Market Size, Anticoagulation Market Growth, Anticoagulation Market Analysis, Anticoagulation Market Report, Anticoagulation Market Share, Anticoagulation Market Trends, Anticoagulation Market Forecast, Anticoagulation Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.Table of Contents
Methodology
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
Key Questions
- • What are some of the most promising, high-growth opportunities for the anticoagulation market by drug class (novel oral anticoagulants, heparin and low molecular weight heparin, vitamin K antagonist, and others), route of administration (oral and injectable), application (atrial fibrillation/myocardial infarction, deep vein thrombosis, pulmonary embolism, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
- • Which segments will grow at a faster pace and why?
- • Which region will grow at a faster pace and why?
- • What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
- • What are the business risks and competitive threats in this market?
- • What are the emerging trends in this market and the reasons behind them?
- • What are some of the changing demands of customers in the market?
- • What are the new developments in the market? Which companies are leading these developments?
- • Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
- • What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
- • What M&A activity has occurred in the last 5 years and what has its impact been on the industry? For any questions related to Anticoagulation Market, Anticoagulation Market Size, Anticoagulation Market Growth, Anticoagulation Market Analysis, Anticoagulation Market Report, Anticoagulation Market Share, Anticoagulation Market Trends, Anticoagulation Market Forecast, Anticoagulation Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
